AbCellera Biologics (ABCL) Current Taxes (2020 - 2022)
AbCellera Biologics' (ABCL) quarterly Current Taxes came in at $23.0 million in Q3 2022, up 249.29% YoY from $6.6 million in Q3 2021, and down 78.55% on a QoQ basis from $107.3 million in Q2 2022.
AbCellera Biologics (ABCL) Current Taxes (2020 - 2022) Analysis & Trends
AbCellera Biologics (ABCL) has 3 years of Current Taxes data on file, last reported at $23.0 million in Q3 2022.
- Quarterly Current Taxes rose 249.29% year-over-year to $23.0 million in Q3 2022, while the trailing twelve-month figure through Sep 2022 was $23.0 million (up 249.29% YoY) and the FY2021 annual result came in at $35.7 million, down 1.3% from the prior year.
- Current Taxes slipped to $23.0 million in Q3 2022, from $107.3 million in the prior quarter.
- In the past five years, Current Taxes ranged from a high of $107.3 million in Q2 2022 to a low of $5.8 million in Q2 2021.
- A 3-year average of $43.8 million and a median of $32.9 million in 2021 frame the typical range for Current Taxes.
- Annual changes were most pronounced in 2021 — Current Taxes retreated 1.3% — and 2022, when it surged 1743.39%.
- Tracing ABCL's Current Taxes over 3 years: stood at $36.2 million in 2020, then retreated by 1.3% to $35.7 million in 2021, then tumbled by 35.49% to $23.0 million in 2022.
- The last three Current Taxes figures came in at $23.0 million (Q3 2022), $107.3 million (Q2 2022), and $105.6 million (Q1 2022), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 49.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 76.32 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 59,089.99 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | AbCellera Biologics | 3.49 Bn | 3.49 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2022 | 23.02 Mn |
| Jun 30, 2022 | 107.32 Mn |
| Mar 31, 2022 | 105.65 Mn |
| Dec 31, 2021 | 35.68 Mn |
| Sep 30, 2021 | 6.59 Mn |
| Jun 30, 2021 | 5.82 Mn |
| Mar 31, 2021 | 30.03 Mn |
| Dec 31, 2020 | 36.15 Mn |